MannKind | MNKD - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Adma Biologics USD 2.15B 2.19B 2026-03
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Insmed USD 23.11B 12.19B 2026-06
Karyopharm Therapeutics USD 126M 9M 2026-03
MacroGenics USD 184M 82M 2026-03
MannKind USD 1.32B 559M 2026-06
Merck USD 317.37B 20.27B 2026-06
Novavax USD 1.09B 316M 2025-12
Novo Nordisk DKK 212.17B 55.02B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Xencor USD 1.19B 301M 2026-06